UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 120

Sortiert nach

Revised Response Criteria for Malignant Lymphoma

Journal of clinical oncology, 2007-02, Vol.25 (5), p.579-586

2007

Volltextzugriff (PDF)

Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias

Cancer research (Chicago, Ill.), 2005-10, Vol.65 (20), p.9152-9154

2005

Volltextzugriff (PDF)

Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

Journal of clinical oncology, 2003-12, Vol.21 (24), p.4642-4649

2003

Volltextzugriff (PDF)

Breast Cancer Risk After Supradiaphragmatic Radiotherapy for Hodgkin's Lymphoma in England and Wales: A National Cohort Study

Journal of clinical oncology, 2012-08, Vol.30 (22), p.2745-2752

2012

Volltextzugriff (PDF)

Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-Refractory Low-Grade or Transformed Low-Grade B-Cell Non-Hodgkin’s Lymphomas

Journal of clinical oncology, 2001-10, Vol.19 (19), p.3918-3928

2001

Volltextzugriff (PDF)

EZH2 Y641 mutations in follicular lymphoma

Leukemia, 2011-04, Vol.25 (4), p.726-729

2011

Volltextzugriff (PDF)

Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias

Cancer research (Chicago, Ill.), 2005-01, Vol.65 (2), p.375-378

2005

Volltextzugriff (PDF)

European Phase II Study of Rituximab (Chimeric Anti-CD20 Monoclonal Antibody) for Patients With Newly Diagnosed Mantle-Cell Lymphoma and Previously Treated Mantle-Cell Lymphoma, Immunocytoma, and Small B-Cell Lymphocytic Lymphoma

Journal of clinical oncology, 2000-01, Vol.18 (2), p.317-324

2000

Volltextzugriff (PDF)

Myeloablative Therapy With Autologous Bone Marrow Transplantation for Follicular Lymphoma at the Time of Second or Subsequent Remission: Long-Term Follow-Up

Journal of clinical oncology, 2007-06, Vol.25 (18), p.2554-2559

2007

Volltextzugriff (PDF)

Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

Journal of clinical oncology, 1999-04, Vol.17 (4), p.1244-1253

1999

Volltextzugriff (PDF)

Number of CD4+ Cells and Location of Forkhead Box Protein P3–Positive Cells in Diagnostic Follicular Lymphoma Tissue Microarrays Correlates With Outcome

Journal of clinical oncology, 2006-11, Vol.24 (31), p.5052-5059

2006

Volltextzugriff (PDF)

Immunohistochemical Prognostic Markers in Diffuse Large B-Cell Lymphoma: Validation of Tissue Microarray As a Prerequisite for Broad Clinical Applications—A Study From the Lunenburg Lymphoma Biomarker Consortium

Journal of clinical oncology, 2007-03, Vol.25 (7), p.805-812

2007

Volltextzugriff (PDF)

Therapy-Related Myelodysplasia and Secondary Acute Myelogenous Leukemia After High-Dose Therapy With Autologous Hematopoietic Progenitor-Cell Support for Lymphoid Malignancies

Journal of clinical oncology, 2000-03, Vol.18 (5), p.947-955

2000

Volltextzugriff (PDF)

Activity of azacitidine in chronic myelomonocytic leukemia

Cancer, 2011-06, Vol.117 (12), p.2690-2696

2011

Volltextzugriff (PDF)

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program

Journal of clinical oncology, 1998-08, Vol.16 (8), p.2825-2833

1998

Volltextzugriff (PDF)

Tositumomab and Iodine I 131 Tositumomab for Recurrent Indolent and Transformed B-Cell Non-Hodgkin’s Lymphoma

Journal of clinical oncology, 2004-04, Vol.22 (8), p.1469-1479

2004

Volltextzugriff (PDF)

Multicenter Phase II Trial of Immunotherapy With the Humanized Anti-CD22 Antibody, Epratuzumab, in Combination With Rituximab, in Refractory or Recurrent Non-Hodgkin's Lymphoma

Journal of clinical oncology, 2006-08, Vol.24 (24), p.3880-3886

2006

Volltextzugriff (PDF)

Array-based DNA methylation profiling in follicular lymphoma

Leukemia, 2009-10, Vol.23 (10), p.1858-1866

2009

Volltextzugriff (PDF)

Lung Cancer After Hodgkin’s Disease: A Nested Case-Control Study of the Relation to Treatment

Journal of clinical oncology, 2001-03, Vol.19 (6), p.1610-1618

2001

Volltextzugriff (PDF)

Multicenter Phase II Study of Fludarabine Phosphate for Patients With Newly Diagnosed Lymphoplasmacytoid Lymphoma, Waldenström's Macroglobulinemia, and Mantle-Cell Lymphoma

Journal of clinical oncology, 1999-02, Vol.17 (2), p.546-553

1999

Volltextzugriff (PDF)

Efficacy and Safety of Oral Fludarabine Phosphate in Previously Untreated Patients With Chronic Lymphocytic Leukemia

Journal of clinical oncology, 2004-04, Vol.22 (7), p.1260-1267

2004

Volltextzugriff (PDF)

International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes

Journal of clinical oncology, 2008-09, Vol.26 (25), p.4124-4130

2008

Volltextzugriff (PDF)

Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma

Annals of oncology, 1994-05, Vol.5 (5), p.397-400

Rohatiner, A.

1994

Volltextzugriff (PDF)

Inhibition of Urinary Bladder Carcinogenesis by Broccoli Sprouts

Cancer research (Chicago, Ill.), 2008-03, Vol.68 (5), p.1593-1600

2008

Volltextzugriff (PDF)

High-Dose Therapy With Autologous Bone Marrow Support as Consolidation of Remission in Follicular Lymphoma: Long-Term Clinical and Molecular Follow-Up

Journal of clinical oncology, 2000-02, Vol.18 (3), p.527-536

2000

Volltextzugriff (PDF)

1 – 25 von 120

Suche als RSS-Feed

Aktive Filter

KollektionOxford University Press Journals Current

ThemaBiological And Medical Sciences

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(109)

Publikationsform

Artikel
(120)

Sprache

Englisch
(120)
Japanisch
(20)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(120)
Medical Sciences
(120)
Science & Technology
(120)
Humans
(116)
Adult
(90)
Middle Aged
(87)
Female
(70)
Male
(70)
Aged
(63)
Pharmacology. Drug Treatments
(54)
Hematologic And Hematopoietic Diseases
(52)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(51)
Antineoplastic Agents
(47)
Chemotherapy
(38)
Hematology
(35)
Adolescent
(30)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(29)
Treatment Outcome
(25)

13 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(29)
British Journal Of Cancer
(15)
Annals Of Oncology
(14)
Hematological Oncology
(10)
Leukemia
(10)
Bone Marrow Transplantation
(8)
Cancer Chemotherapy And Pharmacology
(8)
Cancer Research
(5)
Cancer
(4)
Leukemia Research
(4)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Revised Response Criteria for Malignant Lymphoma

Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias

Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

Breast Cancer Risk After Supradiaphragmatic Radiotherapy for Hodgkin's Lymphoma in England and Wales: A National Cohort Study

Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-Refractory Low-Grade or Transformed Low-Grade B-Cell Non-Hodgkin’s Lymphomas

EZH2 Y641 mutations in follicular lymphoma

Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias

European Phase II Study of Rituximab (Chimeric Anti-CD20 Monoclonal Antibody) for Patients With Newly Diagnosed Mantle-Cell Lymphoma and Previously Treated Mantle-Cell Lymphoma, Immunocytoma, and Small B-Cell Lymphocytic Lymphoma

Myeloablative Therapy With Autologous Bone Marrow Transplantation for Follicular Lymphoma at the Time of Second or Subsequent Remission: Long-Term Follow-Up

Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

Number of CD4+ Cells and Location of Forkhead Box Protein P3–Positive Cells in Diagnostic Follicular Lymphoma Tissue Microarrays Correlates With Outcome

Immunohistochemical Prognostic Markers in Diffuse Large B-Cell Lymphoma: Validation of Tissue Microarray As a Prerequisite for Broad Clinical Applications—A Study From the Lunenburg Lymphoma Biomarker Consortium

Therapy-Related Myelodysplasia and Secondary Acute Myelogenous Leukemia After High-Dose Therapy With Autologous Hematopoietic Progenitor-Cell Support for Lymphoid Malignancies

Activity of azacitidine in chronic myelomonocytic leukemia

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program

Tositumomab and Iodine I 131 Tositumomab for Recurrent Indolent and Transformed B-Cell Non-Hodgkin’s Lymphoma

Multicenter Phase II Trial of Immunotherapy With the Humanized Anti-CD22 Antibody, Epratuzumab, in Combination With Rituximab, in Refractory or Recurrent Non-Hodgkin's Lymphoma

Array-based DNA methylation profiling in follicular lymphoma

Lung Cancer After Hodgkin’s Disease: A Nested Case-Control Study of the Relation to Treatment

Multicenter Phase II Study of Fludarabine Phosphate for Patients With Newly Diagnosed Lymphoplasmacytoid Lymphoma, Waldenström's Macroglobulinemia, and Mantle-Cell Lymphoma

Efficacy and Safety of Oral Fludarabine Phosphate in Previously Untreated Patients With Chronic Lymphocytic Leukemia

International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes

Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma

Inhibition of Urinary Bladder Carcinogenesis by Broccoli Sprouts

High-Dose Therapy With Autologous Bone Marrow Support as Consolidation of Remission in Follicular Lymphoma: Long-Term Clinical and Molecular Follow-Up

Aktive Filter

Suchergebnisse filtern